Biochemical Reagent
-
BA8423 QP5038Summary: QP5038 is an inhibitor. -
BA8424 QR-0217Summary: QR-0217 is a potent aggregation inhibitor. -
BA8425 BF-168Summary: BF-168 is a candidate probe for PET. -
BA8426 OAB-14Summary: OAB-14, a Bexarotene derivative, ameliorates Alzheimer's disease-associated pathology and cognitive deficits by increasing beta-amyloid clearance in APP/PS1 mice. -
BA8427 2-O-Acetyl-20-hydroxyecdysoneSummary: 2-O-Acetyl-20-hydroxyecdysone, an ecdysone present in insects and terrestrial plants, inhibits induced cytotoxicity. -
BA8428 PBD-150Summary: PBD-150 is an inhibitor of the human glutamine acyl cyclase variant. -
BA8429 MK-3328Summary: MK-3328 is a beta-amyloid PET ligand. -
BA8430 FrentizoleSummary: Frentizole, an FDA-approved immunosuppressant. -
BA8431 PQM130Summary: PQM130, a brain-transmitting, weiroxone-donepezil hybrid compound, is a multi-targeted active molecule candidate for neurotoxicity induced by Aβ oligomers, and also possesses anti-inflammatory activity. -
BA8432 RemternetugSummary: Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid βA4 precursor protein) peptide monoclonal antibody.

